Huber, Rudolf M ;
Hansen, Karin H ;
Paz-Ares Rodríguez, Luis...
Huber , R M , Hansen , K H , Paz-Ares Rodríguez , L , West , H L , Reckamp , K L , Leighl , N B , Tiseo , M , Smit , E F , Kim , D W , Gettinger , S N , Hochmair , M J , Kim , S W , Langer , C J , Ahn , M J , Kim , E S , Kerstein , D , Groen , H J M & Camidge , D R 2020 , ' Brigatinib in Crizotinib-Refractory ALK+ NSCLC : 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial ' , Journal of Thoracic Oncology , vol. 15 , no. 3 , pp. 404-415 . https://doi.org/10.1016/j.jtho.2019.11.004.
,
2020